Working… Menu
Trial record 1 of 1 for:    Axcentua
Previous Study | Return to List | Next Study

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01182246
Recruitment Status : Unknown
Verified April 2014 by Axcentua Pharmaceuticals AB.
Recruitment status was:  Recruiting
First Posted : August 16, 2010
Last Update Posted : April 23, 2014
Information provided by (Responsible Party):
Axcentua Pharmaceuticals AB

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2016
Estimated Study Completion Date : March 2016